CureVac | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(1.2%),Peter Kolchinsky(1.2%), etc.
CureVac | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-GSK plc(7.4%)
CureVac | SC 13G: Statement of acquisition of beneficial ownership by individuals-RA Capital Management, L.P.(5.5%),Peter Kolchinsky(5.5%), etc.
CureVac | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Dr. Matthias Hothum(31.7%),MH-LT-Investments GmbH(0.04%)
CureVac | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Bohlini invest GmbH(0.2%),Prof. Dr. Friedrich von Bohlen und Halbach(0.2%)
CureVac | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-4h invest GmbH(0.1%),Dr. Christof Hettich(0.1%)
CureVac | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Dietmar Hopp(37.8%),dievini Hopp BioTech holding GmbH & Co. KG(31.6%), etc.
CureVac | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-KfW(51.44%)
CureVac | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-KfW(52.08%)
CureVac | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Dietmar Hopp(45.2%),dievini Hopp BioTech holding GmbH & Co. KG(37.9%), etc.
CureVac | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Dr. Matthias Hothum(37.9%),MH-LT-Investments GmbH(0.3%)
CureVac | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Bohlini invest GmbH(0.3%),Prof. Dr. Friedrich von Bohlen und Halbach(0.3%)
CureVac | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-4H invest GmbH(0.5%),Dr. Christof Hettich(0.5%)
CureVac | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-4H invest GmbH(0.5%),Dr. Christof Hettich(0.5%)
CureVac | SC 13D: Statement of acquisition of beneficial ownership by individuals-Dr. Matthias Hothum(44.3%),MH-LT-Investments GmbH(0.3%)
CureVac | SC 13D: Statement of acquisition of beneficial ownership by individuals-Prof. Dr. Friedrich von Bohlen und Halbach(44.3%),Bohlini invest GmbH(0.3%)
CureVac | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Dietmar Hopp(46%),dievini Hopp BioTech holding GmbH & Co. KG(44.3%), etc.
CureVac | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Dietmar Hopp(46.2%),dievini Hopp BioTech holding GmbH & Co. KG(45.4%), etc.
CureVac | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Dietmar Hopp(46%),Prof. Dr. Friedrich von Bohlen und Halbach(45.4%), etc.
CureVac | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-KfW(61.8%)
No Data
No Data